LeCointe-Cephas Lisa 4
4 · Merck & Co., Inc. · Filed May 5, 2023
Insider Transaction Report
Form 4
LeCointe-Cephas Lisa
SVP Chief Ethics & Com Officer
Transactions
- Exercise/Conversion
Common Stock
2023-05-03$117.89/sh+689$81,226→ 4,843.693 total - Tax Payment
Common Stock
2023-05-03$117.89/sh−236$27,822→ 4,607.693 total - Exercise/Conversion
Common Stock
2023-05-04$118.22/sh+813$96,113→ 5,420.693 total - Tax Payment
Common Stock
2023-05-04$118.22/sh−279$32,983→ 5,141.693 total - Exercise/Conversion
Restricted Stock Unit
2023-05-03−689→ 1,378 totalFrom: 2023-05-03Exp: 2025-05-03→ Common Stock (689 underlying) - Exercise/Conversion
Restricted Stock Unit
2023-05-04−813→ 816 totalFrom: 2022-05-04Exp: 2024-05-04→ Common Stock (813 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F2]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024, and 5/3/2025.
- [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.